Caffeine
May improve performance in specific tasks; weigh benefits against anxiety and sleep loss.
What it is for
Strength and endurance performance, focus and a lower perception of effort.
How it works
An adenosine receptor antagonist: it reduces the sensation of fatigue and increases central nervous system activation.
Dosing
In healthy adults, start low. EFSA identifies up to 200 mg per dose and 400 mg/day from all sources as generally not raising safety concerns; these are not targets or individual guarantees. Sports doses of 3–6 mg/kg can exceed these reference amounts.
When to take it
30–60 min before exercise. Sleep: as a cautious starting point, allow ≥9 h before bed for about 100 mg (a coffee) and ≥13 h for about 200 mg (a pre-workout). These are population estimates, not guarantees; larger doses may require more time. Deep-sleep changes were observed with 400 mg even 12 h before bed.
Safety
Safe at moderate doses. High doses: anxiety, tachycardia, insomnia.
Side effects
Jitteriness, stomach discomfort, disrupted sleep, mild dependence.
Interactions
It adds to other stimulants; be careful with heavily loaded pre-workouts.
Contraindications
Arrhythmias, uncontrolled hypertension, anxiety, pregnancy (limit to <200 mg/day).
Who it has been studied in
Response depends on dose, sleep, habitual use and other factors. A single genotype cannot reliably predict individual benefit.
Frequently asked
Do you build a tolerance?
Habituation can occur, but stopping does not guarantee renewed ergogenic effects and may cause withdrawal. Routine cycling is unnecessary.
Does it dehydrate you?
The diuretic effect is mild and well tolerated; it is not a practical problem when training.
What this rests on
Wake up and smell the coffee: caffeine supplementation and exercise performance-an umbrella review of 21 published meta-analyses.
Grgic J, Grgic I, Pickering C, et al. · 2019 · British Journal of Sports Medicine
Effect: The umbrella review included 11 reviews and 21 meta-analyses. Average benefits appeared across several outcomes, with varying evidence quality and predominantly young men. Benefits are not consistent across every person, modality, or analysis.
Limitations: Response varies with genetics (caffeine metabolism) and tolerance from habitual intake; most studies use a single laboratory dose, not real daily consumption patterns.
- Evidence tier
- A
- Quality
- High
- Studies
- >100 RCTs, umbrella reviews
- Consensus
- ISSN position in favor
- Controversy
- Effect size varies with genetics (CYP1A2) and habituation
- Reviewed
- 2026
Strength of evidence out of 5.